Opportunity Friday GTVH Down 30% .0493 Oversold MDVL Down 50% 3.58 GOCO Down 40% 4.69 AEYE Down 27% 9.58 ABVC Down 25% 2.71 DWSN Down 25% 1.99 DBGI Down 25% 3.62 ROOT Down 20% 5.54 EFOI Down 15% 3.07 Swings SPONF .0240-.0400 BBIXF .41-1.50 LAAB .36-.51
Pre-Market Winners With News After The Bell BIOL..Up 36% .86 Biolase Significantly Improved Revenue for Q2 On Demand for Their Dental Lasers BOXL...Up 28% 2.46 Q2 Revenue Increased 986% Upgraded to Buys PAYS 2.72...Target Price...3.75 PDSB...10.89...Target Price...15.00 STYH...7.26...Target price..10.00
Pre-Market Memes AMC Down 2% 32.40 First Resistance 30.00 SNDL Down 4% .7960 First Resistance .78 XELA Up 1% 2.97 First Resistance 2.90
BRBL .0141-.033 BBIXF .35-1.50 LAAB .31-1.48 TONR .0004-.0007 LGVN 3.60-6.05 EVK 3.08-4.20 BSQR 2.60-3.17 GMGMF 1.20-2.50 GWHP .38-.70 ACMSY .30-.54 TLMD 2.74-4.66
Buying Opportunity At 52 Week Low ONEM 23.62 1 Life Healthcare Operates a chain of health clinics..Offers in-person in-network primary care, pediatric and family care, and virtual consultations through a network of more than 100 offices in 12 US domestic markets..1 Life works as a provider for over 8,000 organizations Cash 655 million Covers Cash Burn of 37 million Short Term Assets of 756 million Covers Short Term Liabilities of 154 million and Long Term Liabilities of 500 million Revenue grown faster 53% than US Industry average of 19% TipRanks Strong Buy with Target price of 40.50
NEWS AT 2 AM BPTS 8.54 Received Favorable Recommendation From Data Monitoring Committee Based On Safety Analysis Of Sarconeos To Continue Patient Recruitment In The COVA Study In Covid-19 Biophytis is a Bio-Tech focusing on development of therapeutics treating severe respiratory failure in patients suffering from Covid-19 Very Low Float 11 million Median Target Price 12.00
Insider Buying Can Be An Encouraging Sign For Potential Investors Recent heavy Insider Buying ET TVTY MMLP DNB KW FISV COP
Upgraded To Buys By Roth Capital OSS 5.61 Target price 8.50 AXU 1.87 Target price 3.70 UTSI 1.30 Target Price 13.00 VVOS 3.06 Target price 10.00
Pre-Market Memes AMC Up 1% 33.82 Resistance 30.00 SNDL Up 4% .7805 Resistance .78 XELA Up 4% 2.76 Resistance 2.60
Former Meme Has Long Term Upside NAKD.. 270 million in cash and No DEBT Trading pre-Market .53 Resistance .52
Two With Upside TCRX 11.25 Tscan Therapeutics Biopharma researching applications of T-cell immunotherapy..Tscan building of database of clinically relevant data and using it to select TCR'S that show high levels of anti-tumor activity with low side effects. Leading Candidates TSC-100 TSC-101 Are In Liquid Tumor Program Strong Buy With 21.50 Target price ERAS 19.94 Erasca Precision Oncology Company working to develope new anti-cancer drugs Pipeline of 9 separate Drug Candidates Leading Candidate EARS-007 Being studies as treatment for various solid and liquid tumors Strong Buy With Target price 30.20
Maybe Buys At Dips TLMD 2.49 BQSR 2.40 BRQS .73 EVK 2.97 LGVN 3.55 ISWH .66 AIAD .0175 GWHP .39 MSMY .0262 BRBL .0135 XBIO 3.04
